Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
4.220
-0.100 (-2.31%)
At close: Dec 5, 2025, 4:00 PM EST
4.241
+0.021 (0.51%)
After-hours: Dec 5, 2025, 7:24 PM EST
Pyxis Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 2.82 | 16.15 | - | - | - | - | |
| Cost of Revenue | - | 0.48 | - | - | - | - | |
| Gross Profit | 2.82 | 15.67 | - | - | - | - | |
| Selling, General & Admin | 19.44 | 22.49 | 30.83 | 37.35 | 18.66 | 3.85 | |
| Research & Development | 66.01 | 58.75 | 49.59 | 86.13 | 51.05 | 9.05 | |
| Operating Expenses | 85.45 | 81.24 | 80.42 | 123.48 | 69.72 | 12.89 | |
| Operating Income | -82.63 | -65.57 | -80.42 | -123.48 | -69.72 | -12.89 | |
| Interest & Investment Income | 4.63 | 7.04 | 6.63 | 2.76 | 0.02 | 0.07 | |
| Earnings From Equity Investments | - | - | - | - | -0.23 | - | |
| Other Non Operating Income (Expenses) | - | - | - | - | -6.05 | - | |
| EBT Excluding Unusual Items | -78 | -58.53 | -73.79 | -120.72 | -75.98 | -12.83 | |
| Pretax Income | -98.97 | -79.5 | -73.79 | -120.72 | -75.98 | -12.83 | |
| Income Tax Expense | -1.88 | -2.16 | - | - | - | - | |
| Net Income | -97.09 | -77.33 | -73.79 | -120.72 | -75.98 | -12.83 | |
| Net Income to Common | -97.09 | -77.33 | -73.79 | -120.72 | -75.98 | -12.83 | |
| Shares Outstanding (Basic) | 62 | 58 | 40 | 33 | 8 | 1 | |
| Shares Outstanding (Diluted) | 62 | 58 | 40 | 33 | 8 | 1 | |
| Shares Change (YoY) | 13.72% | 46.46% | 20.80% | 288.93% | 724.14% | 53.41% | |
| EPS (Basic) | -1.57 | -1.32 | -1.85 | -3.65 | -8.95 | -12.45 | |
| EPS (Diluted) | -1.57 | -1.32 | -1.85 | -3.65 | -8.95 | -12.45 | |
| Free Cash Flow | -72.37 | -57.91 | -77.44 | -95.73 | -35.87 | -11.57 | |
| Free Cash Flow Per Share | -1.17 | -0.99 | -1.94 | -2.90 | -4.22 | -11.22 | |
| Gross Margin | 100.00% | 97.06% | - | - | - | - | |
| Operating Margin | -2930.25% | -406.11% | - | - | - | - | |
| Profit Margin | -3442.77% | -478.95% | - | - | - | - | |
| Free Cash Flow Margin | -2566.45% | -358.66% | - | - | - | - | |
| EBITDA | -80.47 | -62.59 | -78.49 | -122.77 | -69.07 | -12.43 | |
| D&A For EBITDA | 2.16 | 2.98 | 1.93 | 0.71 | 0.65 | 0.47 | |
| EBIT | -82.63 | -65.57 | -80.42 | -123.48 | -69.72 | -12.89 | |
| Revenue as Reported | 2.82 | 16.15 | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.